CONMED

What CONMED does

CONMED Corporation is a global medical technology company founded in 1970 and publicly traded on NASDAQ under ticker CNMD, headquartered in Largo, Florida with manufacturing operations in Utica, New York; Westborough, Massachusetts; Cordova, Tennessee; and Chihuahua, Mexico. The company designs, manufactures, and distributes surgical devices, implants, and capital equipment across orthopedic and sports medicine, general/laparoscopic/robotic surgery, patient monitoring, and (until its 2026 exit) gastroenterology specialties, serving hospitals, ambulatory surgery centers, and physician offices in over 30 countries.

CONMED's core product platform spans proprietary insufflation (AirSeal iFS), electrosurgical generators (System 2450 and System 5000), smoke evacuation (PlumeSafe X5), surgical power tools (Hall Power, MicroFree), and a deep orthopedic and sports medicine portfolio including the BioBrace reinforced bioinductive implant, Y-Knot and Y-Knotless all-suture anchors, CartiMax viable cartilage allograft, NeoSpan nitinol compression implants, Infinity AIM meniscal repair, and Quantum total ankle system. The portfolio follows a platform-plus-modules architecture where capital equipment generates an installed base that drives high-margin recurring consumables, with approximately 86% of revenue coming from single-use products.

Revenue is generated primarily through a global direct sales force supplemented by regional distributors, with pricing negotiated through hospital, group purchasing organization, and integrated delivery network contracts. FY2025 revenue totaled approximately $1.37 billion with 5.2% constant currency growth, and management has guided to 4.5% to 6.0% organic constant currency growth in FY2026 with a $1.6 billion revenue target by 2028. The company is pursuing a portfolio rationalization strategy that included the 2022 acquisitions of In2Bones Global and Biorez, the 2025-2026 exit from the gastroenterology business, and the recent $150 million share repurchase program alongside a $450 million delayed draw term loan facility.

Name

CONMED

Legal name

CONMED Corporation

Website

https://conmed.com

Company type

Public

Founded year

1970

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

CONMED Corporation is a global medical technology company that designs, manufactures, and distributes surgical devices, implants, and capital equipment for orthopedic, sports medicine, general/laparoscopic/robotic surgery, and patient monitoring, serving hospitals and ambulatory surgery centers in over 30 countries.

Ownership category

akta.pro rank

Product category

Surgical Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industries

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

Keywords

• Surgical medical devices
• Minimally invasive surgery
• Orthopedic implants
• Electrosurgical equipment
• Surgical power tools

Headquarters

HQ city

Utica

HQ country

United States

HQ region

North America

Offices26 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Surgical Devices and Capital Equipment: Sale of reusable surgical equipment including insufflation systems (AirSeal), electrosurgical generators, surgical imaging systems, and power tools. These represent higher-ticket capital purchases with longer replacement cycles.
2. Single-Use Surgical Products (Consumables): Sale of single-use surgical devices and consumables including suture anchors, implants, instruments, smoke evacuation filters, and patient monitoring electrodes. Approximately 86% of revenue comes from single-use products.
3. Implants: Sale of orthopedic implants including suture anchors, interference screws, meniscal repair devices, and biologics like BioBrace and cartilage allografts for sports medicine and orthopedic procedures.
4. Professional Services and Training: Revenue from medical education programs, continuing education opportunities, and training services for healthcare professionals.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

CONMED Corporation designs, manufactures, and distributes surgical devices, capital equipment, and single-use implants for orthopedic, sports medicine, general/laparoscopic/robotic surgery, and patient monitoring. Its portfolio spans capital systems such as AirSeal insufflation, electrosurgical generators, Hall surgical power tools, and surgical imaging, complemented by approximately 86% of revenue from single-use consumables including suture anchors, biologics (BioBrace, CartiMax), smoke evacuation filters, electrodes, and fixation devices.

Product overview

CONMED Corporation is a medical device company offering a comprehensive surgical equipment and consumables portfolio organized across multiple product categories: Orthopedics & Sports Medicine (implants, suture anchors, fixation devices, surgical power tools, biologics), General/Laparoscopic/Robotic Surgery (AirSeal insufflation systems, electrosurgical units, smoke evacuation, surgical instruments, imaging), Gastroenterology (biliary products, hemostasis clips, polypectomy devices), and Patient Monitoring (ECG/EEG electrodes, IV stabilization). The portfolio includes flagship products like the BioBrace reinforced bioinductive implant for soft tissue repair, AirSeal iFS intelligent insufflation system, Y-Knot suture anchors, CartiMax cartilage allograft, and the Hall Power surgical tool line with 55+ year heritage. The company operates a platform-plus-modules architecture with core technology systems (energy, insufflation, smoke evacuation) supplemented by procedure-specific consumables and implants.

Differentiator

Problem solved

Functional benefit

Brands

• BioBrace: Reinforced bioinductive implant combining collagen with PLLA microfilaments for tendon healing
• AirSeal
• Hall Power
• CartiMax
• Y-Knot

Products and services

• BioBrace Reinforced Bioinductive Implant Soft tissue augmentation implant combining highly porous Type I collagen with PLLA microfilaments for mechanical strength to support tendon healing and tissue growth; targets sports medicine and orthopedic surgeons.
• AirSeal iFS Intelligent Flow System

Quantifiable outcome

• AirSeal iFS positively affects patient intra and postoperative outcomes (clinical data backing)
• +2 more outcomes

Segments5 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Micro-Tech EndoscopyminorChannel Partner/ Reseller/ Distributor · 18 March 2026Micro-Tech Endoscopy acquired global distribution rights for CONMED's Duraclip, Precisor, and Optibite product lines following CONMED's strategic decision to exit the gastroenterology market. This transaction enables CONMED to transition GI products to a specialized distributor while focusing on core surgical areas.
• BiorezcoreStrategic or Co-development Partner · 2 August 2022CONMED acquired Biorez for $85 million with potential earnout payments up to $165 million. Biorez developed the BioBrace implant technology, an FDA-cleared reinforced bioinductive implant for soft tissue repair that enhances CONMED's sports medicine portfolio.
• In2Bones GlobalcoreStrategic or Co-development Partner · 31 May 2022CONMED announced plans to acquire In2Bones Global using proceeds from a $600 million convertible senior notes offering. In2Bones is a medical device company specializing in foot and ankle reconstruction products, strengthening CONMED's orthopedic portfolio.
• W.L. Gore & AssociatesminorChannel Partner/ Reseller/ DistributorCONMED previously held exclusive US and Canadian distribution rights for Gore's VIABIL biliary stent. This distribution agreement was terminated as part of CONMED's strategic exit from the gastroenterology market effective January 1, 2026.

Scale indicators11 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Zimmer Biomet: Zimmer Biomet is one of the largest pure-play orthopedic medical device companies, with leadership in joint reconstruction, sports medicine, surgical, and biologics. It competes with CONMED in suture anchors, soft tissue repair, and extremity/foot & ankle reconstruction (overlapping with In2Bones and Quantum Total Ankle).
• Olympus: Olympus is the global leader in endoscopy and minimally invasive surgical visualization. Its laparoscopic and arthroscopic imaging systems compete directly with CONMED's surgical imaging franchise, and it sells complementary energy and insufflation devices.
• Stryker: Stryker is a leading global medical device company with major franchises in orthopedic implants, sports medicine (arthroscopy), surgical instruments, and endoscopy. It is the most directly comparable peer to CONMED across general surgery, MIS, and orthopedic sports medicine, competing head-to-head on suture anchors, power tools, and visualization.
• Smith+Nephew: Smith+Nephew is a UK-headquartered medical device company with strong franchises in orthopedic reconstruction, sports medicine (arthroscopic anchors, meniscal repair), and advanced wound management. Its sports medicine portfolio directly overlaps with CONMED's Y-Knot, Sequent, and BioBrace franchises.
• Arthrex: Arthrex is a private, orthopedic-focused medical device company dominating sports medicine, arthroscopy, and soft tissue repair. Its suture anchor, biologic, and arthroscopic instrument portfolios are direct substitutes for CONMED's core orthopedic and sports medicine products.
• Integra LifeSciences: Integra LifeSciences is a mid-cap specialty medical device company focused on neurosurgery, ENT, and orthopedics/tissue technologies. It is a direct peer in specialty orthopedic soft tissue repair and biologics, with comparable scale to CONMED.

Broad incumbents

• Johnson & Johnson MedTech: Johnson & Johnson's MedTech division (including Ethicon and DePuy Synthes) dominates surgical stapling, energy devices, sutures, and orthopedic reconstruction. It is a broad incumbent that competes with CONMED across nearly every product category in the OR and orthopedic settings.
• Becton Dickinson (BD): BD is a large medical technology company with a leading Medical and Procedural Solutions segment that includes surgical instruments, biosciences, and procedure solutions. It competes with CONMED in electrosurgical, patient monitoring electrodes, and surgical instruments.
• Medtronic: Medtronic is a diversified medical technology leader with a large Surgical and Respiratory Interventions portfolio covering electrosurgical, insufflation, smoke evacuation, and stapling. It is a broad incumbent competitor to CONMED in the OR and laparoscopic surgery markets.
• Boston Scientific: Boston Scientific is a large diversified medtech company with strong franchises in endoscopy, urology, and peripheral interventions. It overlaps with CONMED in urology and gynecology instruments and electrosurgical/energy devices through its legacy products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/conmedlinvatec
• LinkedInlinkedin.com/company/conmed-corporation

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries5 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A6 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CONMED